In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers sought to determine the percentage of COVID-19 patients discharged from the hospital ...
Dec 2, 2022
0
31
Between 1980 and 2014, the rate of death from chronic respiratory diseases, such as COPD, increased by nearly 30 percent overall in the U.S., although this trend varied by county, sex, and chronic respiratory disease type, ...
Sep 26, 2017
0
1
New lung research from an international team of scientists could offer doctors a new way to detect and monitor progressive lung diseases—and may also shed light on the fundamental causes of those conditions.
Feb 1, 2022
0
5
Chronic respiratory diseases (CRDs) were the third leading cause of death globally, accounting for 4.0 million deaths in 2019, according to a study published online April 25 in eClinicalMedicine.
May 18, 2023
0
25
Some diseases involve autoimmune reactions when the body begins to attack its own cells and proteins. The biological mechanisms underlying these diseases are often unknown, making treatment challenging. Now, a group at TMDU ...
Apr 11, 2024
0
11
The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society's American Journal of Respiratory and Critical ...
Feb 1, 2019
0
1
Many diseases show major differences in their prevalence from one country to another, but it is often unclear whether this is due to lifestyle and environmental factors such as the diet, the genetic backgrounds in different ...
Mar 12, 2019
0
0
Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency (CVID). Therapeutically ...
Mar 7, 2019
0
1
There has been an increase in deaths and disability due to chronic respiratory (lung) diseases over the past three decades, finds an analysis of data from 195 countries published by The BMJ today.
Feb 19, 2020
0
2
The U.S. Food and Drug Administration approved the first therapy in its class to reduce the frequency of bone marrow suppression induced by chemotherapy for extensive-stage small cell lung cancer, the agency announced Friday.
Feb 19, 2021
0
2
